9.00
price up icon7.14%   0.60
pre-market  Vorhandelsmarkt:  9.05   0.05   +0.56%
loading
Schlusskurs vom Vortag:
$8.40
Offen:
$8.7
24-Stunden-Volumen:
414.75K
Relative Volume:
2.39
Marktkapitalisierung:
$192.40M
Einnahmen:
$66.59M
Nettoeinkommen (Verlust:
$-104.93M
KGV:
-1.8182
EPS:
-4.95
Netto-Cashflow:
$-96.48M
1W Leistung:
+4.05%
1M Leistung:
+26.58%
6M Leistung:
+15.68%
1J Leistung:
-30.12%
1-Tages-Spanne:
Value
$8.33
$9.17
1-Wochen-Bereich:
Value
$8.33
$9.17
52-Wochen-Spanne:
Value
$4.09
$13.37

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name
Firmenname
Enanta Pharmaceuticals Inc
Name
Telefon
617 607 0800
Name
Adresse
4 KINGSBURY AVENUE, WATERTOWN, MA
Name
Mitarbeiter
131
Name
Twitter
@EnantaPharma
Name
Nächster Verdiensttermin
2025-02-10
Name
Neueste SEC-Einreichungen
Name
ENTA's Discussions on Twitter

Vergleichen Sie ENTA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ENTA
Enanta Pharmaceuticals Inc
9.00 179.57M 66.59M -104.93M -96.48M -4.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
401.00 100.25B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.90 61.55B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.00 58.53B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
706.41 43.59B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
332.04 33.67B 3.81B -644.79M -669.77M -6.24

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-28 Fortgesetzt H.C. Wainwright Buy
2023-08-09 Herabstufung JP Morgan Neutral → Underweight
2023-08-08 Herabstufung Jefferies Buy → Hold
2022-12-09 Eingeleitet H.C. Wainwright Buy
2022-07-06 Hochstufung Evercore ISI In-line → Outperform
2022-06-01 Hochstufung Evercore ISI Underperform → In-line
2021-10-07 Eingeleitet Jefferies Buy
2021-09-09 Eingeleitet SVB Leerink Mkt Perform
2021-01-29 Hochstufung JP Morgan Underweight → Neutral
2020-11-24 Eingeleitet Evercore ISI Underperform
2020-08-28 Fortgesetzt ROTH Capital Buy
2020-08-26 Eingeleitet Piper Sandler Overweight
2020-07-27 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
2020-03-17 Hochstufung Robert W. Baird Neutral → Outperform
2019-11-22 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2019-09-26 Herabstufung JP Morgan Neutral → Underweight
2019-05-24 Eingeleitet Wolfe Research Outperform
2019-04-23 Hochstufung Berenberg Hold → Buy
2018-12-13 Eingeleitet Berenberg Hold
2018-06-06 Eingeleitet ROTH Capital Buy
2018-02-08 Herabstufung JP Morgan Overweight → Neutral
2018-01-02 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2017-11-21 Bestätigt RBC Capital Mkts Outperform
2017-09-15 Eingeleitet RBC Capital Mkts Outperform
2017-07-11 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
2016-04-28 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 Bestätigt Barclays Underweight
2015-10-23 Herabstufung Barclays Equal Weight → Underweight
2015-10-23 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
Alle ansehen

Enanta Pharmaceuticals Inc Aktie (ENTA) Neueste Nachrichten

pulisher
09:04 AM

Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial a - PharmiWeb.com

09:04 AM
pulisher
07:21 AM

Live market analysis of Enanta Pharmaceuticals Inc.Portfolio Profit Report & Weekly Stock Performance Updates - Newser

07:21 AM
pulisher
07:05 AM

Enanta Pharmaceuticals announces passing of longtime CFO Paul Mellett - Investing.com

07:05 AM
pulisher
06:50 AM

Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Price Is Right But Growth Is Lacking After Shares Rocket 27% - simplywall.st

06:50 AM
pulisher
06:45 AM

Enanta Pharmaceuticals: Leadership Continuity and Strategic Resilience in Biotech R&D - AInvest

06:45 AM
pulisher
06:26 AM

Enanta Pharmaceuticals Receives New 'Buy' Rating from WestPark Capital with $24.00 Price Target - AInvest

06:26 AM
pulisher
06:15 AM

Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial and Administrative Officer Paul J. Mellett Jr. | ENTA Stock News - GuruFocus

06:15 AM
pulisher
06:03 AM

Enanta Pharmaceuticals Announces Passing of Chief Financial and Administrative Officer Paul J. Mellett Jr. - AInvest

06:03 AM
pulisher
06:00 AM

Two Decades of Leadership: Enanta Pharmaceuticals Mourns Loss of CFO Who Helped Cure 1M+ HCV Patients - Stock Titan

06:00 AM
pulisher
05:09 AM

How to build a custom watchlist for Enanta Pharmaceuticals Inc.July 2025 Big Picture & Technical Pattern Recognition Alerts - Newser

05:09 AM
pulisher
05:00 AM

Historical volatility pattern of Enanta Pharmaceuticals Inc. visualizedTrade Entry Report & Short-Term Trading Opportunity Alerts - Newser

05:00 AM
pulisher
04:58 AM

Measuring Enanta Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser

04:58 AM
pulisher
04:49 AM

Published on: 2025-09-03 03:49:04 - Newser

04:49 AM
pulisher
04:02 AM

Short interest data insights for Enanta Pharmaceuticals Inc.Insider Selling & Precise Buy Zone Tips - Newser

04:02 AM
pulisher
03:41 AM

How to build a dashboard for Enanta Pharmaceuticals Inc. stockJuly 2025 Macro Moves & Advanced Technical Signal Analysis - Newser

03:41 AM
pulisher
01:44 AM

Using data filters to optimize entry into Enanta Pharmaceuticals Inc.Index Update & Technical Pattern Based Buy Signals - Newser

01:44 AM
pulisher
01:28 AM

Can you recover from losses in Enanta Pharmaceuticals Inc.2025 Investor Takeaways & Expert Approved Trade Ideas - Newser

01:28 AM
pulisher
12:01 PM

Real time social sentiment graph for Enanta Pharmaceuticals Inc.Trend Reversal & Accurate Entry/Exit Alerts - Newser

12:01 PM
pulisher
Sep 02, 2025

Is Enanta Pharmaceuticals Inc. reversing from oversold territory2025 Technical Patterns & AI Driven Price Predictions - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Key resistance and support levels for Enanta Pharmaceuticals Inc.July 2025 Short Interest & Long-Term Growth Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Enanta Pharmaceuticals Inc. forming a breakout patternJuly 2025 Movers & Technical Buy Zone Confirmations - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

What’s the outlook for Enanta Pharmaceuticals Inc.’s sector2025 Momentum Check & Free High Accuracy Swing Entry Alerts - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

What recovery options are there for Enanta Pharmaceuticals Inc.Market Risk Report & Community Trade Idea Sharing Platform - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can momentum traders help lift Enanta Pharmaceuticals Inc.2025 Sector Review & Consistent Profit Trading Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Enanta Pharma (ENTA) Receives New 'Buy' Rating from WestPark Capital | ENTA Stock News - GuruFocus

Sep 02, 2025
pulisher
Sep 02, 2025

Enanta Pharmaceuticals: WestPark Capital initiates coverage with a Buy rating and $24 PT. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Tools to monitor Enanta Pharmaceuticals Inc. recovery probabilityJuly 2025 Momentum & Accurate Trade Setup Notifications - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How to manage a losing position in Enanta Pharmaceuticals Inc.2025 Price Action Summary & Community Driven Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Aug Chart Watch: Will Enanta Pharmaceuticals Inc. be affected by tariffsJuly 2025 Retail & Weekly High Return Forecasts - خودرو بانک

Sep 02, 2025
pulisher
Sep 01, 2025

Can Enanta Pharmaceuticals Inc. rally from current levelsWeekly Profit Report & AI Based Buy and Sell Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Visualizing Enanta Pharmaceuticals Inc. stock with heatmapsWeekly Trade Report & Weekly High Potential Stock Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Using data tools to time your Enanta Pharmaceuticals Inc. exit2025 Earnings Surprises & Fast Moving Market Watchlists - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

What MACD and RSI say about Enanta Pharmaceuticals Inc.2025 Sector Review & Safe Entry Zone Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Enanta Pharmaceuticals Inc. see short term momentumPortfolio Update Summary & Reliable Intraday Trade Plans - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

What recovery options are there for Enanta Pharmaceuticals IncJuly 2025 WrapUp & Fast Gain Stock Tips - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

How high can Enanta Pharmaceuticals Inc. stock goTrade Analysis Summary & Real-Time Price Movement Reports - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is a relief rally coming for Enanta Pharmaceuticals Inc. holdersTrade Signal Summary & Safe Entry Trade Signal Reports - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Is Enanta Pharmaceuticals Inc. building a consolidation baseJuly 2025 Sector Moves & Stepwise Trade Execution Plans - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Is Enanta Pharmaceuticals Inc. stock bottoming outJuly 2025 Breakouts & Reliable Trade Execution Plans - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Applying Elliott Wave Theory to Enanta Pharmaceuticals Inc.Earnings Risk Report & Daily Growth Stock Tips - Newser

Aug 29, 2025

Finanzdaten der Enanta Pharmaceuticals Inc-Aktie (ENTA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$25.89
price up icon 4.10%
$85.98
price up icon 1.62%
$23.84
price up icon 0.59%
$100.62
price up icon 0.62%
$145.30
price up icon 6.76%
biotechnology ONC
$332.04
price up icon 8.49%
Kapitalisierung:     |  Volumen (24h):